A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response

Pharmacogenetics

Volumn 13, Issue 1, 2003, Pages 7-17

  Liljedah, Ulrika ^a   Karlsson, Julia ^a   Melhus, Håtkan ^a   Kurland, Lisa ^a   Lindersson, Marie ^a   Kahan, Thomas ^b   Nyström, Fredrik ^c   Lind, Lars ^a   Syvänen, Ann Christine ^d  

^a UPPSALA UNIVERSITY   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diastolic blood pressure; Genotyping; Haplotype; Microarrays; Minisequencing; Pharmacogenetics; Single nucleotide polymorphism; Systolic blood pressure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DNA POLYMERASE; IRBESARTAN;

ADULT; ALLELISM; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DNA MICROARRAY; FEMALE; FLUORESCENCE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHARMACOGENETICS; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; TREATMENT OUTCOME; TREATMENT PLANNING;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; DATABASES, GENETIC; DNA PRIMERS; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RANDOM ALLOCATION; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN;

EID: 0037249383     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200301000-00003     Document Type: Article

References (33)

1. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409:928-933.
2. Venter JC, Adams MD, Myers EW, Li PW, Mural R J, Sutton GG, et al. The sequence of the human genome. Science 2001; 291:1304-1351.
3. Guyton AC, Hall JE, Lohmeier TE, Jackson TE, Kastner PR. Blood pressure regulation: basic concepts. Fed Proc 1981; 40:2252-2256.
4. Hong Y, de Faire U, Heller DA, McClearn GE, Pedersen N. Genetic and environmental influences on blood pressure in elderly twins. Hypertension 1994; 24:663-670.
5. Pausova Z, Gossard F, Gaudet D, Tremblay J, Kotchen TA, Cowley AW, et al. Heritability estimates of obesity measures in siblings with and without hypertension. Hypertension 2001; 38:41-47.
6. Weder AB, Schork NJ. Adaptation, allometry, and hypertension. Hypertension 1994; 24:145-156.
7. Turner ST, Schwartz GL, Chapman AB, Hall WD, Boerwinkle E. Antihypertensive pharmacogenetics: getting the right drug into the right patient. J Hypertens 2001; 19:1-11.
8. Laragh JH, Lamport B, Sealey J, Alderman MH. Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment. Hypertension 1988; 12:223-226.
9. Lind L, Berne C, Andersson PE, Hanni A, Lithell H. Is insulin resistance a predictor of the blood pressure response to anti-hypertensive treatment? J Hum Hypertens 1995; 9:759-763.
10. Kurland L, Melhus H, Karlsson J: Kahan T, Malmqvist K, Ohman KP, et al. Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients. J Hypertens 2001; 19:1783-1787.
11. Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman P, et al. AIdosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. Am J Hypertens 2002; 15:389-393.
12. Syvanen AC, Sajantila A, Lukka M. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am J Hum Genet 1993; 52:46-59.
13. Syvanen AC. From gels to chips: 'minisequencing'; primer extension for analysis of point mutations and single nucleotide polymorphisms. Hum Mutat 1999; 13:1-10.
14. Pastinen T, Raitio M, Lindroos K, Tainola P, Peltonen L, Syvanen AC. A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. Genome Res 2000; 10:1031-1042.
15. Malmqvist K, Kahan T, Edner M, Held C, Hagg A, Lind L, et al. Regression of left ventricular hypertrophy in human hypertension with irbesartan. J Hypertens 2001; 19:1167-1176.
16. Raitio M, Lindroos K, Laukkanen M, Pastinen T, Sistonen P, Sajantila A, et al. Y-chromosomal SNPs in Finno-Ugric-speaking populations analyzed by minisequencing on microarrays. Genome Res 2001; 11:471-482.
17. Lindroos K, Liljedahl U, Raitio M, Syvanen AC. Minisequencing on oligonucleotide microarrays: comparison of immobilisation chemistries. Nucleic Acids Res 2001; 29:E69.
18. Olsson C, Waldenstrom E, Westermark K, Landegren U, Syvanen AC. Determination of the frequencies of 10 allelic variants of the Wilson disease gene (ATP7B), in pooled DNA samples. Eur J Hum Genet 2000; 8:933-938.
19. Raymond M, Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Hered 1995; 86:248-249.
20. Hawley ME, Kidd KK. HAPLO: a program using the EM algorithm to estimate the frequencies of multi-site haplotypes. J Hered 1995; 86:409-411.
21. Johnson GC, Esposito L, Barratt B J, Smith AN, Heward J, Di Genova G, et al. Haplotype tagging for the identification of common disease genes. Nature Genet 2001; 29:233-237.
22. Maison P, Byrne CD, Hales CN, Wareham NJ. Hypertension and its treatment influence changes in fasting nonesterified fatty acid concentrations: a link between the sympathetic nervous system and the metabolic syndrome? Metabolism 2000; 49:81-87.
23. Filipovsky J, Ducimetiere P, Eschwege E, Richard JL, Rosselin G, Claude JR. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens 1996; 14:229-235.
24. Grimsgaard S, Bonaa KH, Jacobsen BK, Bjerve KS. Plasma saturated and linoleic fatty acids are independently associated with blood pressure. Hypertension 1999; 34:478-483.
25. Syvanen AC. Accessing genetic variation: genotyping single nucleotide polymorphisms. Nature Rev Genet 2001; 2:930-942.
26. Martin ER, Lai EH, Gilbert JR, Rogala AR, Afshari AJ, Riley J, et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 2000; 67:383-394.
27. Grupe A, Germer S, Usuka J, Aud D, Belknap JK, Klein RF, et al. In silico mapping of complex disease-related traits in mice. Science 2001; 292:1915-1918.
28. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA 2001; 98:581-584.
29. Fan JB, Chen X, Halushka MK, Berno A, Huang X, Ryder T, et al. Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res 2000; 10:853-860.
30. Hirschhorn JN, Sklar P, Lindblad-Toh K, Lim YM, Ruiz-Gutierrez M, Bolk S, et al. SBE-TAGS: an array-based method for efficient single-nucleotide polymorphism genotyping. Proc Natl Acad Sci USA 2000; 97: 12164-12169.
31. Lindroos K, Sigurdsson S, Johansson K, Ronnblom L, Syvanen AC. Multiplex SNP genotyping in pooled DNA samples by a four-colour microarray system. Nucleic Acids Res 2002; 30:E70.
32. Tonisson N, Zernant J, Kurg A, Pavel H, Slavin G, Roomere H, et al. Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene. Proc Natl Acad Sci USA 2002; 99:5503-5508.
33. Terwilliger JD, Goring HH. Gene mapping in the 20th and 21st centuries: statistical methods, data analysis, and experimental design. Hum Biol 2000; 72:63-132.